Skip to main content
Mural Oncology PLC logo

Mural Oncology PLC — Investor Relations & Filings

Ticker · MURA ISIN · IE000LK2BOB4 BUD Professional, scientific and technical activities
Open in API
Filings indexed 192 across all filing types
Latest filing 2025-12-16 Major Shareholding Noti…
Country IE Ireland
Listing BUD MURA

About Mural Oncology PLC

https://www.muraloncology.com/

Mural Oncology PLC is a clinical-stage biotechnology company that discovers and develops immunotherapies for cancer treatment. The company leverages its proprietary protein engineering platform to create novel, cytokine-based therapies. Its primary focus is on developing first- and best-in-class drugs for difficult-to-treat tumor types where other immunotherapies, such as checkpoint inhibitors, have not been effective. The company's pipeline is led by nemvaleukin alfa, a novel, engineered IL-2 variant immunotherapy. This candidate is being evaluated in clinical trials for various advanced solid tumors, including platinum-resistant ovarian cancer and advanced melanoma, addressing areas of high unmet medical need.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-12-16 English
15-12G
Regulatory Filings Classification · 100% confidence The document is a Form 15 filed with the SEC, which is a certification and notice of termination of registration under Section 12(g) of the Securities Exchange Act of 1934 or suspension of duty to file reports under Sections 13 and 15(d). It is a regulatory filing notifying the SEC and the public that the company is terminating its registration and suspending its reporting obligations. The document is short (1689 characters) and is a formal notice rather than a financial report or detailed filing. This fits the category of Regulatory Filings (RNS), which includes compliance documents and notices that do not fit other specific categories.
2025-12-15 English
Regulatory Filings 2025
Regulatory Filings
2025-12-09 English
S-8 POS
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to Form S-8 Registration Statements filed with the SEC. It relates to deregistration of securities following an acquisition transaction. The document is a regulatory filing concerning securities registration and deregistration, not a financial report, earnings release, or presentation. It is a formal SEC filing about share registration status and termination of offerings, fitting the category of Regulatory Filings (RNS). The document length is about 5,490 characters, and it contains detailed legal and regulatory information about the registration statements and their termination, not financial data or management discussion. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-12-05 English
S-8 POS
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to Form S-8 Registration Statements filed with the SEC. It relates to deregistration of securities following an acquisition transaction. The document primarily deals with the termination of securities offerings and removal of unsold securities from registration. It is a regulatory filing concerning securities registration and deregistration, not a financial report, earnings release, or other report types. The document is about capital structure changes but specifically relates to deregistration of securities under Form S-8, which is a registration statement for employee stock plans. This fits best under Transaction in Own Shares (POS) as it involves removal of registered shares following acquisition and termination of offerings. The document length is about 5,490 characters, and it contains substantive content, not just an announcement or certification. Therefore, the classification is POS with high confidence.
2025-12-05 English
S-8 POS
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to Form S-8 Registration Statements filed with the SEC. It discusses deregistration of securities following an acquisition and termination of offerings under the registration statements. The document is a regulatory filing related to securities registration and deregistration, not a financial report, earnings release, or other report type. It is a formal SEC filing concerning securities registration status and amendments, fitting the Regulatory Filings (RNS) category as it does not contain financial statements or detailed financial data but is a compliance and regulatory update.
2025-12-05 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.